{"id":"dwj1276","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Without publicly available clinical trial data or mechanism disclosures, the precise molecular target and pharmacological action of DWJ1276 remain unknown. As a phase 3 candidate, it has progressed through early safety and efficacy testing, but detailed mechanistic information is not yet in the public domain.","oneSentence":"DWJ1276 is an investigational therapeutic agent in phase 3 development by Daewoong Pharmaceutical, but its specific mechanism of action has not been publicly disclosed.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:46:06.754Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT01764295","phase":"PHASE3","title":"Clinical Study for Patients With Hypertension Associated With Dyslipidemia","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2012-09","conditions":"Hypertension, Dyslipidemia","enrollment":150},{"nctId":"NCT01823900","phase":"PHASE1","title":"Safety and Pharmacokinetic Comparison of Co-administration and a Combination Drug of Rosuvastatin and Olmesartan in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Severance Hospital","startDate":"2012-01","conditions":"Healthy","enrollment":58},{"nctId":"NCT01493856","phase":"PHASE1","title":"A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2012-01","conditions":"Healthy Volunteers","enrollment":58}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"DWJ1276","genericName":"DWJ1276","companyName":"Daewoong Pharmaceutical Co. LTD.","companyId":"daewoong-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DWJ1276 is a medication being studied in a clinical trial for the treatment of hypertension associated with dyslipidemia. The trial is a multi-institutional, randomized, double-blind, placebo-controlled study comparing DWJ1276 to olmesartan and rosuvastatin.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}